Weight-loss drug Ozempic, renowned for its remarkable effectiveness in tackling obesity and managing diabetes, is set to make an exciting debut in India. This launch arrives just in time to meet the rising demand for innovative weight management solutions
Eli Lilly’s recent launch of its weight-loss drug in India is set to transform the competitive landscape of the burgeoning market. With obesity rates rising, rivals are now poised to accelerate their efforts to capture a share of this lucrative opportunity.
Eli Lilly is set to introduce its weight-loss drug in emerging markets this year, aiming to address rising obesity rates. The launch follows successful outcomes in developed regions, positioning Lilly to expand its global footprint in the competitive weight management sector.
